Calyxo, Inc. recalls CVAC Aspiration System
- Published
- 2 Apr 2025
- Units affected
- 11,246
- Agency
- FDA
- Country
- United States
The hazard
Aspiration system, for endoscopic examination/treatment of urinary tract and kidney interior, to have labeling update adding additional instructions, for patients with high viscosity fluid in the kidney, not to continue providing fluid inflow in the presence of unresolved slow or absent fluid outflow because this can create intrarenal pressure imbalance, and lead to excessive intrarenal pressure.
Classification: Class I — the most serious type: there is a reasonable chance this product could cause serious health problems or death.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
CVAC Aspiration System, REF: CVC127020-1, and User Manual L00018. Intended for endoscopic examination/treatment of urinary tract and kidney interior.
- Brand / company
- Calyxo, Inc.
- Codes / lots
- CVC127020-1 UDI-DI: 00860005357710, L00018 Rev C
- Distribution
- US Nationwide distribution including in the states of AL, AZ, CA, CO, CT, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NH, NJ, NM, NV, OH, OK, OR, PA, SC, TN, TX, UT, VA, VT, WA, WI, WV.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 2 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.